{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:13:29Z","timestamp":1789676009357,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"DOI":"10.1007\/s12185-026-04286-z","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:54:53Z","timestamp":1789674893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coagulation profiles and factor XIII activity in pediatric patients with severe motor and intellectual disability: a multicenter exploratory study"],"prefix":"10.1007","author":[{"given":"Ryohei","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-2782","authenticated-orcid":false,"given":"Yuto","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Omae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Kirimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Yasuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Ebisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Ogitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Minowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"issue":"7","key":"4286_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/s0387-7604(98)00038-2","volume":"20","author":"M Kurihara","year":"1998","unstructured":"Kurihara M, Kumagai K, Noda Y, Watanabe M, Imai M. Prognosis in severe motor and intellectual disabilities syndrome complicated by epilepsy. Brain Dev. 1998;20(7):519\u201323. https:\/\/doi.org\/10.1016\/s0387-7604(98)00038-2.","journal-title":"Brain Dev"},{"key":"4286_CR2","first-page":"648","volume":"35","author":"K Oshima","year":"1971","unstructured":"Oshima K. Basic issue on severe motor and intellectual disabilities. Nippon Koshu Eisei Zasshi. 1971;35:648\u201355.","journal-title":"Nippon Koshu Eisei Zasshi"},{"issue":"11","key":"4286_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cppeds.2024.101673","volume":"54","author":"DR Patel","year":"2024","unstructured":"Patel DR, Bovid KM, Rausch R, Ergun-Longmire B, Goetting M, Merrick J. Cerebral palsy in children: a clinical practice review. Curr Probl Pediatr Adolesc Health Care. 2024;54(11):101673. https:\/\/doi.org\/10.1016\/j.cppeds.2024.101673.","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"3","key":"4286_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-9993(94)90023-x","volume":"75","author":"RT Radecki","year":"1994","unstructured":"Radecki RT, Gaebler-Spira D. Deep vein thrombosis in the disabled pediatric population. Arch Phys Med Rehabil. 1994;75(3):248\u201350. https:\/\/doi.org\/10.1016\/0003-9993(94)90023-x.","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"4286_CR5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3400\/avd.oa.13-00090","volume":"6","author":"H Ohmori","year":"2013","unstructured":"Ohmori H, Ochi F, Tanuma N, Ohnuki E, Yamasaki M, Takesue H, et al. Deep vein thrombosis in patients with severe motor and intellectual disabilities. Ann Vasc Dis. 2013;6(4):694\u2013701. https:\/\/doi.org\/10.3400\/avd.oa.13-00090.","journal-title":"Ann Vasc Dis"},{"issue":"1","key":"4286_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3944\/AOTT.2011.2472","volume":"45","author":"H Omero\u011flu","year":"2011","unstructured":"Omero\u011flu H, Inan U, Turgut K, Harman\u015fa S. Preoperative hematological assessment of pediatric patients with cerebral palsy. Acta Orthop Traumatol Turc. 2011;45(1):1\u20135. https:\/\/doi.org\/10.3944\/AOTT.2011.2472.","journal-title":"Acta Orthop Traumatol Turc"},{"key":"4286_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2019.04.019","volume":"98","author":"R Kumar","year":"2019","unstructured":"Kumar R, Vidaurre J, Gedela S. Valproic acid-induced coagulopathy. Pediatr Neurol. 2019;98:25\u201330. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2019.04.019.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"4286_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.0013-9580.2004.28302.x","volume":"45","author":"M Teich","year":"2004","unstructured":"Teich M, Longin E, Dempfle CE, K\u00f6nig S. Factor XIII deficiency associated with valproate treatment. Epilepsia. 2004;45(2):187\u20139. https:\/\/doi.org\/10.1111\/j.0013-9580.2004.28302.x.","journal-title":"Epilepsia"},{"key":"4286_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.67","volume":"3","author":"ZA Bhutta","year":"2017","unstructured":"Bhutta ZA, Berkley JA, Bandsma RHJ, Kerac M, Trehan I, Briend A. Severe childhood malnutrition. Nat Rev Dis Primers. 2017;3:17067. https:\/\/doi.org\/10.1038\/nrdp.2017.67.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"4286_CR10","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/jth.14022","volume":"16","author":"K Nogami","year":"2018","unstructured":"Nogami K, Matsumoto T, Tabuchi Y, Soeda T, Arai N, Kitazawa T, et al. Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa\/factor X bispecific antibody emicizumab. J Thromb Haemost. 2018;16(6):1078\u201388. https:\/\/doi.org\/10.1111\/jth.14022.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"4286_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/ijlh.12724","volume":"39","author":"PO Sevenet","year":"2017","unstructured":"Sevenet PO, Depasse F. Clot waveform analysis: where do we stand in 2017? Int J Lab Hematol. 2017;39(6):561\u20138. https:\/\/doi.org\/10.1111\/ijlh.12724.","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"4286_CR12","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1111\/hae.13266","volume":"23","author":"T Matsumoto","year":"2000","unstructured":"Matsumoto T, Nogami K, Tabuchi Y, Yada K, Ogiwara K, Kurono H, et al. Clot waveform analysis using CS-2000i\u2122 distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A. Haemophilia. 2000;23(5):e427-435. https:\/\/doi.org\/10.1111\/hae.13266.","journal-title":"Haemophilia"},{"issue":"2","key":"4286_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12185-021-03249","volume":"115","author":"M Takeyama","year":"2022","unstructured":"Takeyama M, Sasai K, Matsumoto T, Furukawa S, Ogiwara K, Yada K, et al. Comprehensive blood coagulation potential in patients with acquired hemophilia A: Retrospective analyses of plasma samples obtained from nationwide centers across Japan. Int J Hematol. 2022;115(2):163\u201372. https:\/\/doi.org\/10.1007\/s12185-021-03249.","journal-title":"Int J Hematol"},{"issue":"1","key":"4286_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s12185-017-2213-5","volume":"106","author":"T Ishihara","year":"2017","unstructured":"Ishihara T, Nogami K, Matsumoto T, Nomura A, Takeshita Y, Ochi S, et al. Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation. Int J Hematol. 2017;106(1):126\u201334. https:\/\/doi.org\/10.1007\/s12185-017-2213-5.","journal-title":"Int J Hematol"},{"key":"4286_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.thromres.2018.12.016","volume":"174","author":"H Yoshizawa","year":"2019","unstructured":"Yoshizawa H, Nogami K, Matsumoto T, Tsujii N, Sakai T, Takase T, et al. Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays. Thromb Res. 2019;174:76\u201383. https:\/\/doi.org\/10.1016\/j.thromres.2018.12.016.","journal-title":"Thromb Res"},{"issue":"9","key":"4286_CR16","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1055\/s-0040-1713890","volume":"120","author":"T Onishi","year":"2020","unstructured":"Onishi T, Nogami K, Ishihara T, Inoue S, Kawaguchi M, Nishio K, et al. A pathological clarification of sepsis-associated disseminated intravascular coagulation based on comprehensive coagulation and fibrinolysis function. Thromb Haemost. 2020;120(9):1257\u201369. https:\/\/doi.org\/10.1055\/s-0040-1713890.","journal-title":"Thromb Haemost"},{"issue":"2","key":"4286_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1034\/j.1600-0404.2003.00149.x","volume":"108","author":"B Pohlmann-Eden","year":"2003","unstructured":"Pohlmann-Eden B, Peters CN, Wennberg R, Dempfle CE. Valproate induces reversible factor XIII deficiency with risk of perioperative bleeding. Acta Neurol Scand. 2003;108(2):142\u20135. https:\/\/doi.org\/10.1034\/j.1600-0404.2003.00149.x.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"4286_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264351","volume":"17","author":"DS Post","year":"2022","unstructured":"Post DS, van der Veer A, Schijns OEMG, Klinkenberg S, Rijkers K, Wagner GL, et al. Assessment of need for hemostatic evaluation in patients taking valproic acid: a retrospective cross-sectional study. PLoS ONE. 2022;17(2):e0264351. https:\/\/doi.org\/10.1371\/journal.pone.0264351.","journal-title":"PLoS ONE"},{"issue":"3","key":"4286_CR19","first-page":"457","volume":"43","author":"M Morimoto","year":"2018","unstructured":"Morimoto M, Hamada S, Kitaoka T, Kyotani S. Effects of prescription intervention by pharmacists on multidrug therapy in patients with severe motor and intellectual disabilities. J Jpn Soc Severe Mot Intellect Disabil. 2018;43(3):457\u201364.","journal-title":"J Jpn Soc Severe Mot Intellect Disabil"},{"issue":"1","key":"4286_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40801-020-00221-8","volume":"8","author":"A Negishi","year":"2021","unstructured":"Negishi A, Oshima S, Horii N, Mutoh M, Inoue N, Numajiri S, et al. Categorisation of pharmaceutical adverse events using the Japanese adverse drug event report database: characteristic adverse drug events of the elderly treated with polypharmacy. Drugs Real World Outcomes. 2021;8(1):49\u201361. https:\/\/doi.org\/10.1007\/s40801-020-00221-8.","journal-title":"Drugs Real World Outcomes"},{"issue":"5","key":"4286_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1517\/17425250902927386","volume":"5","author":"DN Assis","year":"2009","unstructured":"Assis DN, Navarro VJ. Human drug hepatotoxicity: a contemporary clinical perspective. Expert Opin Drug Metab Toxicol. 2009;5(5):463\u201373. https:\/\/doi.org\/10.1517\/17425250902927386.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"4286_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/17425255.2025.2468200","volume":"21","author":"HK Bj\u00f6rnsson","year":"2025","unstructured":"Bj\u00f6rnsson HK, Bj\u00f6rnsson ES. Risk factors and prediction for DILI in clinical practice. Expert Opin Drug Metab Toxicol. 2025;21(5):579\u201387. https:\/\/doi.org\/10.1080\/17425255.2025.2468200.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"4286_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11606-014-2993-8","volume":"30","author":"W Leiss","year":"2015","unstructured":"Leiss W, M\u00e9an M, Limacher A, Righini M, Jaeger K, Beer HJ, et al. Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism. J Gen Intern Med. 2015;30(1):17\u201324. https:\/\/doi.org\/10.1007\/s11606-014-2993-8.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"4286_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-0036-1572326","volume":"42","author":"L Muszbek","year":"2016","unstructured":"Muszbek L, Katona \u00c9. Diagnosis and management of congenital and acquired FXIII deficiencies. Semin Thromb Hemost. 2016;42(4):429\u201339. https:\/\/doi.org\/10.1055\/s-0036-1572326.","journal-title":"Semin Thromb Hemost"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04286-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04286-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04286-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:54:54Z","timestamp":1789674894000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04286-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":24,"alternative-id":["4286"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04286-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RK, TK, TO, TO, YT, TS, MH, SY, AK, HY, RE, NY, AO, EW, YT and HM have no disclosure of conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}